OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Spremljeno u:
Bibliografski detalji
Glavni autori: Salmon-Céron, D, Durier, C, Desaint, C, Cuzin, Surenaud, M, Hénin, Y, Lelièvre, J, Bonnet, B, Pialoux, G, Poizot-Martin, I, Ben Hamouda, N, Jackson, A, Flys, C, Guérin, C, Aboulker, J, Choppin, J, Launay, O
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2009
Teme:
Oral Presentation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2767546/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4690-6-S3-O25
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items